For quality assurance professionals, sustainability can sometimes feel like a difficult conversation. On one side, organisations are under growing pressure to reduce waste, lower energy consumption, cut carbon emissions and improve environmental performance. On the other hand, GMP environments are built on control, consistency, validation, documentation and patient safety.
So, can sustainability and GMP work together?
The answer is yes, but only when sustainability is approached through the right quality lens. In regulated life sciences, sustainability cannot be treated as a shortcut, a cost-saving exercise or a reason to weaken controls. It must be embedded into the Pharmaceutical Quality System, supported by quality risk management and assessed with the same discipline as any other GMP-impacting change.
GMP exists to ensure products are consistently produced and controlled to the quality standards appropriate for their intended use. The World Health Organization describes GMP as part of a quality management system, primarily aimed at reducing inherent risks in pharmaceutical production, including cross-contamination, mix-ups and false labelling. That purpose must remain non-negotiable. Sustainability can support better operations, but it cannot override the duty to protect the patient.
Sustainability Is Not Separate from Quality
One of the biggest mistakes companies can make is placing sustainability outside the quality framework. If sustainability initiatives sit only within facilities, procurement or ESG reporting, QA may be brought in too late. By that stage, decisions may already have been made about materials, suppliers, cleaning processes, packaging, equipment, utilities or waste reduction.
A stronger approach is to involve QA from the beginning. Sustainability initiatives should be assessed for potential impact on product quality, validated processes, contamination control, data integrity, regulatory filings, supplier qualification and batch release. This does not mean QA should block innovation. It means QA should help shape sustainable change in a compliant, evidence-based way.
ISPE describes sustainability in pharmaceutical manufacturing as the implementation of systems and processes to assess and control environmental impacts and health and safety hazards when producing pharmaceutical products. That definition aligns well with how QA professionals already think: identify risk, control risk, document decisions and verify outcomes.
Quality Risk Management Is the Bridge
The natural bridge between sustainability and GMP is quality risk management. ICH Q9(R1) provides principles and examples of tools that can be applied across the pharmaceutical lifecycle, including development, manufacturing, distribution, inspection and regulatory review processes. This makes QRM an essential tool when assessing whether a sustainability change is acceptable.
For example, a site may want to reduce water usage in cleaning processes. From a sustainability perspective, this may be positive. From a GMP perspective, QA must ask: does the revised cleaning process still meet validated acceptance criteria? Has the change been assessed for residue risk, microbiological risk and cross-contamination risk? Is revalidation required? Are operators trained? Are procedures updated?
The same thinking applies to energy reduction in controlled environments, reusable packaging, lower-impact raw materials, solvent recovery, reduced sampling, paperless records or waste segregation. Each idea may bring environmental benefit, but each must be evaluated for GMP impact before implementation.
The FDA’s guidance on ICH Q9(R1) notes that the purpose of quality risk management is to support better, more informed and timely decisions. It also highlights issues such as subjectivity in risk assessments and the need for clearer risk-based decision-making. For QA leaders, this is especially relevant. Sustainability decisions must not be based on good intentions alone. They need a structured risk assessment, scientific justification and documented approval.
Where Sustainability and GMP Can Align
There are many areas where sustainability and GMP can complement each other.
Digital documentation is one example. Moving from paper-based systems to validated electronic quality management systems can reduce paper use while improving document control, audit trails, review efficiency and data accessibility. However, this only works if electronic systems are validated, secure and compliant with data integrity expectations.
Process optimisation is another opportunity. Reducing unnecessary rework, deviations, batch failures and rejected materials is both a quality improvement and a sustainability improvement. Every failed batch represents wasted raw materials, energy, labour, packaging and time. A strong right-first-time culture supports compliance and reduces environmental impact.
Supplier qualification can also play a role. QA teams can work with procurement to consider supplier sustainability credentials while still prioritising GMP compliance, material quality, change notification, traceability and supply reliability. A supplier should not be selected on sustainability claims alone, but environmental performance can become part of a broader supplier oversight model.
Cleaning and sterilisation processes may also offer opportunities, provided changes are properly validated. More efficient cycles, improved scheduling, better equipment design and reduced unnecessary repetition can lower resource use without compromising contamination control.
Cold chain and distribution can benefit from route optimisation, improved packaging design and better shipment consolidation. However, any change must protect temperature control, product stability and GDP requirements.
The QA Role: Challenge, Enable and Protect
QA teams have a crucial role to play in making sustainability practical. They should not be seen as the department that says no. Instead, they should be the function that asks the questions needed to make sustainable change robust.
Key QA questions include:
- Does this change affect product quality, safety, efficacy or compliance?
- Has a formal quality risk assessment been completed?
- Is validation, qualification or requalification required?
- Are regulatory commitments or marketing authorisations affected?
- Are procedures, batch records or training materials impacted?
- Is there a risk to contamination control, cleaning effectiveness or environmental monitoring?
- Are suppliers, materials or specifications changing?
- How will success be measured and monitored after implementation?
These questions help sustainability initiatives move from aspiration to controlled execution.
The EU GMP Chapter 1 draft guidance describes quality management as a wide-ranging concept covering all matters that influence product quality, and states that GMP applies across lifecycle stages from investigational medicinal products and technology transfer through to commercial manufacturing and product discontinuation. This lifecycle view gives QA professionals a strong platform to support sustainability from development through routine production and beyond.
Beware of “Green” Changes Without GMP Evidence
Sustainability language can be persuasive, but QA teams must remain evidence-led. Claims such as “eco-friendly”, “recyclable”, “low carbon”, “reduced waste” or “energy efficient” do not automatically mean GMP-compatible.
For example, changing to a recyclable packaging component may seem positive, but QA must assess compatibility, extractables and leachables where relevant, sterility assurance, transport protection, labelling durability and supplier controls. Reducing environmental monitoring frequency may save consumables, but it could weaken contamination control if not scientifically justified. Lowering HVAC usage may reduce energy consumption, but it could compromise room classification, temperature, humidity, pressure differentials or microbial control.
In other words, sustainability cannot be used as a rationale for reducing control unless the scientific and regulatory case is clear.
Building a Sustainable Quality Culture
The most successful organisations will be those that make sustainability part of quality culture, not a competing priority. This means training QA teams to understand sustainability goals, while also training sustainability and operations teams to understand GMP responsibilities.
Cross-functional collaboration is essential. QA, engineering, validation, manufacturing, supply chain, EHS, regulatory affairs and procurement should work together from the earliest stage of any sustainability project. When these teams collaborate early, they are more likely to identify solutions that are both environmentally responsible and GMP-compliant.
Sustainability should also be included in management review where relevant. Metrics such as deviation reduction, batch yield improvement, waste reduction, energy efficiency, water usage, right-first-time performance and supplier performance can show how quality and sustainability are linked.
Final Thoughts
Sustainability and GMP can work together, but only when patient safety remains the anchor. QA professionals are uniquely positioned to lead this balance because they understand systems, risk, documentation, compliance and continuous improvement.
The future of pharmaceutical and life sciences manufacturing will demand cleaner, more efficient and more responsible operations. However, the industry cannot afford sustainability initiatives that weaken control or introduce hidden risk. The QA perspective is therefore essential.
The goal is not sustainability, instead of GMP. The goal is sustainability through GMP: controlled, justified, documented and continuously improved.
For QA talent, managers and teams, this is an opportunity to lead. By bringing quality thinking into sustainability decisions, QA Resources can help organisations reduce environmental impact while protecting the standards that matter most: product quality, compliance and patient safety.